[go: up one dir, main page]

DE60201921D1 - Kondensierte Pyrazolverbindungen - Google Patents

Kondensierte Pyrazolverbindungen

Info

Publication number
DE60201921D1
DE60201921D1 DE60201921T DE60201921T DE60201921D1 DE 60201921 D1 DE60201921 D1 DE 60201921D1 DE 60201921 T DE60201921 T DE 60201921T DE 60201921 T DE60201921 T DE 60201921T DE 60201921 D1 DE60201921 D1 DE 60201921D1
Authority
DE
Germany
Prior art keywords
independently
pyrazole compounds
condensed pyrazole
compounds
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60201921T
Other languages
English (en)
Other versions
DE60201921T2 (de
Inventor
Kuo Sheng-Chu
Fang Yu Lee
Che-Ming Teng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yung Shin Pharm Industries Co Ltd
Original Assignee
Yung Shin Pharm Industries Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yung Shin Pharm Industries Co Ltd filed Critical Yung Shin Pharm Industries Co Ltd
Publication of DE60201921D1 publication Critical patent/DE60201921D1/de
Application granted granted Critical
Publication of DE60201921T2 publication Critical patent/DE60201921T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE60201921T 2001-01-24 2002-01-24 Kondensierte Pyrazolverbindungen Expired - Fee Related DE60201921T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26378201P 2001-01-24 2001-01-24
US263782P 2001-01-24

Publications (2)

Publication Number Publication Date
DE60201921D1 true DE60201921D1 (de) 2004-12-23
DE60201921T2 DE60201921T2 (de) 2005-10-06

Family

ID=23003205

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60201921T Expired - Fee Related DE60201921T2 (de) 2001-01-24 2002-01-24 Kondensierte Pyrazolverbindungen
DE60216610T Expired - Fee Related DE60216610T2 (de) 2001-01-24 2002-01-24 Verwendung von kondensierten Pyrazolverbindungen für die Herstellung eines Arzneimittels zur Behandlung von Bluthochdruck

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60216610T Expired - Fee Related DE60216610T2 (de) 2001-01-24 2002-01-24 Verwendung von kondensierten Pyrazolverbindungen für die Herstellung eines Arzneimittels zur Behandlung von Bluthochdruck

Country Status (8)

Country Link
US (1) US6518294B2 (de)
EP (1) EP1227099B1 (de)
CN (1) CN1393446B (de)
AT (2) ATE347556T1 (de)
CA (1) CA2369232C (de)
DE (2) DE60201921T2 (de)
HK (1) HK1050194A1 (de)
TW (1) TWI250161B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077702A1 (en) * 2001-09-14 2004-04-22 Wen-Mei Fu Treatment of nuerodegenerative diseases
US7345079B2 (en) * 2001-12-26 2008-03-18 Yung Shin Pharmaceuticals Industrial Co., Ltd Treatment of disorder related to low cyclic GMP levels
WO2003061651A1 (en) * 2002-01-22 2003-07-31 The Regents Of The University Of California Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
US7166293B2 (en) * 2002-03-29 2007-01-23 Carlsbad Technology, Inc. Angiogenesis inhibitors
US20050096370A1 (en) * 2003-04-07 2005-05-05 Bizbiotech Co., Ltd. Method for inhibiting tumor angiogenesis and tumor growth
US7226941B2 (en) 2003-06-30 2007-06-05 Hif Bio, Inc. Compound for treating angiogenesis
TW200520760A (en) * 2003-12-15 2005-07-01 Alcon Inc Substituted [1,4] oxazino [2,3-g] indazoles for the treatment of glaucoma
GB0405933D0 (en) * 2004-03-16 2004-04-21 Glaxo Group Ltd Compounds
CN100516049C (zh) * 2004-11-16 2009-07-22 永信药品工业股份有限公司 抗血管生成药n2-(取代的芳基甲基)-3-(取代的苯基)吲唑的合成
EP1916896A4 (de) * 2005-08-26 2010-08-11 Univ California Nichtsteroid-antiandrogene
US20080252028A1 (en) * 2007-04-16 2008-10-16 Ming-Tai Huang Shock absorbing device for toy stroller

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2928079B2 (ja) 1994-02-14 1999-07-28 永信薬品工業股▲ふん▼有限公司 １−（置換ベンジル）−３−（置換アリール）縮合ピラゾール類、その製造法及びその用途
DE19642255A1 (de) 1996-10-14 1998-04-16 Bayer Ag Verwendung von 1-Benzyl-3-(substituierten-hetaryl) -kondensierten Pyrazol-Derivaten
IT1295384B1 (it) 1997-10-23 1999-05-12 Snam Progetti Rivestimento protettivo di apparecchiature a pressione utilizzabili in processi per la sintesi dell'urea
US6387942B2 (en) * 2000-06-19 2002-05-14 Yung Shin Pharmaceutical Ind. Co. Ltd Method of treating disorders related to protease-activated receptors-induced cell activation

Also Published As

Publication number Publication date
EP1227099A1 (de) 2002-07-31
CA2369232C (en) 2010-05-25
HK1050194A1 (en) 2003-06-13
DE60216610T2 (de) 2007-10-11
CN1393446B (zh) 2010-06-16
US20030004355A1 (en) 2003-01-02
ATE282622T1 (de) 2004-12-15
TWI250161B (en) 2006-03-01
ATE347556T1 (de) 2006-12-15
CN1393446A (zh) 2003-01-29
EP1227099B1 (de) 2004-11-17
US6518294B2 (en) 2003-02-11
DE60201921T2 (de) 2005-10-06
DE60216610D1 (de) 2007-01-18
CA2369232A1 (en) 2002-07-24

Similar Documents

Publication Publication Date Title
ATE319446T1 (de) Neue prolinverbindungen als mikrobizide mittel
DE69820248D1 (de) Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben
DK0418845T3 (da) Pyrazolderivater, fremgangsmåder til fremstilling deraf og farmaceutisk præparat omfattende samme
NO913750D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
MXPA02011974A (es) Derivados de quinazolina sustituidos y su uso como inhibidores.
ATE404561T1 (de) Neue adeninderivate
WO2001009103A3 (en) Imidazole antiproliferative agents
CA2272291A1 (en) Crf antagonistic quino- and quinazolines
EP1533304A4 (de) Amidderivat
DE60328035D1 (de) Neue azolderivate
DE60201921D1 (de) Kondensierte Pyrazolverbindungen
EA200000614A1 (ru) 2,3-замещенные соединения индола в качестве ингибиторов сох-2
WO2003064429A1 (fr) Thienopyrimidines, procedes de fabrication et d'utilisation correspondants
AP9901578A0 (en) Sulfonylbenzene compounds as anti-inflammatory/analgesic agents.
ATE259376T1 (de) Heterozyklische verbindungen, ihre zwischenprodukte und elastase-inhibitoren
DE69839753D1 (de) 2-(Arylphenyl)amino-imidazolin-Derivate
EP0921122A4 (de) Neue epoxysuccinamid-derivate oder ihre salze
WO2003031414A1 (fr) Nouveau compose heterocyclique et agent anti-inflammatoire
IL161842A (en) 2-amino-4-heteroarylethyl-thiazoline derivatives and pharmaceutical compositions comprising them
FI935798A0 (fi) Alkylsubstituerade heterocykliska foereningar
DE69226931D1 (de) Guanidinothiazolederivate und ihre Anwendung als H2-Rezeptor-Antagonisten
DE60001205D1 (de) Azolderivative oder deren Salze
WO2002026230A1 (fr) Remedes contre les troubles inflammatoires des intestins
IL155183A (en) Oxapenam - 3 - Carboxylic acids, pharmaceutical preparations containing it and their use
DK0823254T3 (da) Hidtil ukendt anvendelse af pyrazolopyridinforbindelser

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee